More international pressure to waive local clinical study for new drugs.

American pharmaceutical research based manufacturers association (PhRMA) requested USTR to designate Korea along with Argentina as the country of first convention (PFC) in connection with the exemption of local clinical study for new drugs and protection of intellectual property rights.

It is therefore foreseen that USTR may give pressures to Korea for opening and expanding the drug ...